Clinical Trial: DR-01-ONC-001

Trial Status: Open
Disease Types: Leukemia, Lymphoma
Trial ID DR-01-ONC-001
Sponsor ID Dren Bio

A Multicenter, Open-Label, First-in-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Locations

Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID ADCT-402-105
Sponsor ID LOTIS-7

A Phase 1b Open-Label Study to Evaluate the Safety and Anti-Cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-Cancer Agents in Patients with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

Principal Investigator
Mitul Gandhi, MD
1 Location
Trial ID SLSG18-301
Sponsor ID Sellas

A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator’s Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy

Principal Investigator
Mitul Gandhi, MD
5 Locations